BioCare Introduces Quality and Regulatory Consultancy Service
QRCare aims to help manufacturing partners in a variety of compliance and regulatory needs
Specialty therapy distributor BioCare has announced the launch of QRCare, a quality and regulatory consultancy service that provides BioCare‘s partners with the support needed to develop and maintain strategic quality and regulatory efforts.
QRCare offers assistance to customers throughout their quality and regulatory journeys, whether they are establishing a system from the ground up, preparing for a supply chain inspection or implementing change control, the company reports.
QRCare is led by industry experts Kathleen Hopping, vice president of regulatory affairs, and Peggy Yena, vice president of quality. “The patient experience drives everything we do,” said Hopping. “By offering much-needed assistance to specialty drug manufacturers and partners, we are ultimately enabling critically needed and potentially life-saving medications to be available to patient populations sooner.”
“Our goal is to be the most trusted quality and regulatory experts for our partners,” added Yena.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
